首页 › 基金 › CLARK ESTATES INC/NY › STTK
CLARK ESTATES INC/NY 对 STTK 的持仓历史
SHATTUCK LABS INC · 医疗保健
CLARK ESTATES INC/NY 在 Q3 2026 的 13F 申报中披露持有 STTK(SHATTUCK LABS INC)1,416,447 股,市值约 US$9.7M,约占其申报组合的 2.24%,在其申报持仓中市值排名第 12 位。 CLARK ESTATES INC/NY 最近 13 个申报季度中有 13 个季度披露了 STTK 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
CLARK ESTATES INC/NY 对 STTK 的持仓演变
CLARK ESTATES INC/NY 于 Q3 2023 首次披露 STTK 持仓:1,475,648 股(约 US$2.2M)。 该持仓在 Q1 2024 达到峰值 1,475,648 股,市值约 US$13.2M。 在 13 次申报中,CLARK ESTATES INC/NY 0 次增持、2 次减持、10 次保持不变。 最近一期申报(Q3 2026)显示持股 1,416,447 股、市值约 US$9.7M,环比减持 -13,720 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 1.48M | $2.24M | 新进 |
| Q4 2023 | 1.48M | $10.52M | 持有 |
| Q1 2024 | 1.48M | $13.19M | 持有 |
| Q2 2024 | 1.48M | $5.70M | 持有 |
| Q3 2024 | 1.48M | $5.15M | 持有 |
| Q4 2024 | 1.48M | $1.79M | 持有 |
| Q1 2025 | 1.48M | $1.40M | 持有 |
| Q2 2025 | 1.48M | $1.17M | 持有 |
| Q3 2025 | 1.48M | $3.53M | 持有 |
| Q4 2025 | 1.48M | $5.39M | 持有 |
| Q1 2026 | 1.48M | $9.49M | 持有 |
| Q2 2026 | 1.43M | $9.93M | 减持 |
| Q3 2026 | 1.42M | $9.66M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 STTK 与 13F 数据
STTK(SHATTUCK LABS INC)属于医疗保健行业。我们追踪的基金中还有 59 只申报持有 STTK,申报仓位最大的包括:Redmile Group, LLC (US$47.8M), ORBIMED ADVISORS LLC (US$43.8M), Prosight Management, LP (US$41.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 STTK 的基金
- Redmile Group, LLC 6.89M 股 · $47.83M · Q2 2026
- ORBIMED ADVISORS LLC 6.31M 股 · $43.76M · Q2 2026
- Prosight Management, LP 5.96M 股 · $41.35M · Q2 2026
- Frazier Life Sciences Management, L.P. 3.75M 股 · $26.02M · Q2 2026
- Deep Track Capital, LP 3.71M 股 · $25.72M · Q2 2026
- NEXTBio Capital Management LP 3.73M 股 · $25.42M · Q3 2026
- Boxer Capital Management, LLC 1.00M 股 · $6.94M · Q2 2026
- S&G Foundation 435.75K 股 · $2.97M · Q3 2026
- West Tower Group, LLC 191.62K 股 · $1.31M · Q3 2026
- LBJ Family Wealth Advisors, Ltd. 82.18K 股 · $560.00K · Q3 2026
更多关于 CLARK ESTATES INC/NY
常见问题
How long has CLARK ESTATES INC/NY held STTK?
CLARK ESTATES INC/NY has disclosed STTK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is CLARK ESTATES INC/NY's current position in STTK?
As of Q3 2026, CLARK ESTATES INC/NY holds 1.42M shares of STTK (SHATTUCK LABS INC), valued at $9.66M, representing 2.24% of its reported portfolio and ranking #12.
Has CLARK ESTATES INC/NY been buying or selling STTK?
In the latest 13F filing (Q3 2026), CLARK ESTATES INC/NY reduced its position in STTK. The position peaked in Q1 2024 at 1.48M shares.
Which other funds hold STTK?
Other major institutional holders of STTK include Redmile Group, LLC, ORBIMED ADVISORS LLC, Prosight Management, LP, among 59 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.